Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.

Fukaya H, Ako J, Yasuda S, Kaikita K, Akao M, Matoba T, Nakamra M, Miyauchi K, Hagiwara N, Kimura K, Hirayama A, Matsui K, Ogawa H

Open source

DOI
10.1136/heartjnl-2021-319321
Published
2021 Nov
Container
Heart (British Cardiac Society)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/heartjnl-2021-319321,
  title = {Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.},
  author = {Fukaya H and Ako J and Yasuda S and Kaikita K and Akao M and Matoba T and Nakamra M and Miyauchi K and Hagiwara N and Kimura K and Hirayama A and Matsui K and Ogawa H},
  year = {2021},
  journal = {Heart (British Cardiac Society)},
  doi = {10.1136/heartjnl-2021-319321},
  url = {https://doi.org/10.1136/heartjnl-2021-319321}
}

RIS

TY  - JOUR
TI  - Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.
AU  - Fukaya H
AU  - Ako J
AU  - Yasuda S
AU  - Kaikita K
AU  - Akao M
AU  - Matoba T
AU  - Nakamra M
AU  - Miyauchi K
AU  - Hagiwara N
AU  - Kimura K
AU  - Hirayama A
AU  - Matsui K
AU  - Ogawa H
PY  - 2021
JO  - Heart (British Cardiac Society)
DO  - 10.1136/heartjnl-2021-319321
UR  - https://doi.org/10.1136/heartjnl-2021-319321
ER  - 

APA

H, F., J, A., S, Y., K, K., M, A., T, M., M, N., K, M., N, H., K, K., A, H., K, M., & H, O. (2021). Aspirin versus P2Y(12) inhibitors with anticoagulation therapy for atrial fibrillation.. Heart (British Cardiac Society). https://doi.org/10.1136/heartjnl-2021-319321

Source records